3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
3SBio (1530)
Assess today's live 3SBio (1530) share price, performance and insights using our live Hong Kong: 1530 stock exchange data.
Analyse the historical data and 3SBio share price performance charts on this page. Our technical summary section provides analysis on 3SBio share price buy/sell indicators using real-time data (or discuss the 3SBio (1530) stock price today with other investors in the 3SBio HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK 1530 share price (ISIN: KYG8875G1029) to enhance your trading decisions with our free investment tools and resources.
What Is the 3SBio Share Price Today?
The 3SBio share price today is 26.48.
What Is the Stock Symbol for 3SBio
The stock symbol (or 'ticker') for 01530 is "1530."
What Stock Exchange Does 3SBio Trade On?
01530 is listed and trades on the Hong Kong stock exchange.
Is 3SBio a Good Stock to Buy?
Determining whether 01530—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and 3SBio share price performance charts on this page. Our technical summary section provides analysis on 3SBio share price buy/sell indicators using real-time data (or discuss the 3SBio (1530) stock price today with other investors in the 3SBio HK share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current HK 1530 share price (ISIN: KYG8875G1029) to enhance your trading decisions with our free investment tools and resources.
What Is the 3SBio Share Price Today?
The 3SBio share price today is 26.48.
What Is the Stock Symbol for 3SBio
The stock symbol (or 'ticker') for 01530 is "1530."
What Stock Exchange Does 3SBio Trade On?
01530 is listed and trades on the Hong Kong stock exchange.
Is 3SBio a Good Stock to Buy?
Determining whether 01530—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Hong Kong
Currency in HKD
26.48
-0.48(-1.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.10
27.20
52 wk Range
5.81
36.80
1530 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.1027.20
52 wk Range
5.8136.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
1530 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
38.99
Upside
+47.24%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro - 3SBio receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
3SBio Company Profile
3SBio Inc., an investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; and Cipterbin, an anti-HER2 monoclonal antibody for the treatment of advanced HER2-positive breast cancer and pan-HER2. It also offers Yisaipu, the receptor fusion tumor necrosis factor inhibitor; EPIAO and SEPO, an erythropoietin injection; Mandi-minoxidil, an OTC external medicine for treating hair loss; and SPARIN, an injectable low-molecular-weight heparin calcium. In addition, the company provides Remitch, a nalfuraphine hydrochloride orally disintegrating tablets; MN709, a minoxidil foam formulation for the treatment of androgenetic alopecia and alopecia areata; and other products in the areas of nephrology, hematology, oncology, auto-immune, ophthalmology, and dermatology and metabolism. Further, it engages in trading; research and development of biotechnology and drugs; sells chemical products; and retail of pharmaceuticals. Additionally, the company provides project management and consultation, technology, sports, financial, clinic, investment advisory, and agricultural services, as well as manufactures medical devices. 3SBio Inc. was founded in 1993 and is headquartered in Shenyang, the People’s Republic of China.
Compare 1530 to Peers and Sector
Metrics to compare | 1530 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship1530PeersSector | |
|---|---|---|---|---|
P/E Ratio | 25.1x | 35.2x | −0.6x | |
PEG Ratio | 0.61 | 0.27 | 0.00 | |
Price/Book | 3.6x | 2.5x | 2.6x | |
Price / LTM Sales | 6.5x | 5.7x | 3.4x | |
Upside (Analyst Target) | 44.4% | 26.4% | 41.3% | |
Fair Value Upside | Unlock | 14.4% | 4.9% | Unlock |
Analyst Ratings
14 Buy
1 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 38.99
(+47.24% Upside)
Earnings
Latest Release
Sep 30, 2025
EPS / Forecast
0.56 / --
Revenue / Forecast
4.36B / --
People Also Watch
FAQ
What Is the 3SBio (1530) Share Price Today?
The live 3SBio share price today is 26.48
What Stock Exchange Does 3SBio (1530) Trade On?
3SBio is listed and trades on the Hong Kong Stock Exchange.
What Is the Ticker (Stock Symbol) for 3SBio?
The stock symbol (also called a 'ticker') for 3SBio is "1530."
Does 3SBio Pay Dividends? What’s The Current 1530 Dividend Yield?
Yes, 1530 Pays Dividends to its Shareholders. The current 3SBio dividend yield is 0.93%.
What Is the Current 3SBio Market Cap?
As of today, 3SBio market capitalisation is 65.69B.
What Is 3SBio's (1530) Earnings Per Share (TTM)?
The 3SBio EPS is currently 0.96 (Trailing Twelve Months).
Is 1530 a Buy or Sell From a Technical Analyst Perspective?
Based on today's 3SBio moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has 3SBio Stock Split?
3SBio has split 0 times. (See the 1530 stock split history page for full effective split date and price information.)
How Many Employees Does 3SBio Have?
3SBio has 6268 employees.
What is the current trading status of 3SBio (1530)?
As of 16 Jan 2026, 3SBio (1530) is trading at a price of 26.48, with a previous close of 26.96. The stock has fluctuated within a day range of 26.10 to 27.20, while its 52-week range spans from 5.81 to 36.80.
What Is 3SBio (1530) Price Target According to Analysts?
The average 12-month price target for 3SBio is HKD38.98843743, with a high estimate of HKD48.66017461 and a low estimate of HKD25.1152899. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +47.24% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.